- Country: Ukraine
- Summary: Ciprofloxacin Solution for Infusions, 2 Mg/Ml of 100 Ml; Levonorgestrel, Intrauterine System, 52 Mg; Human Anti-D Immunoglobulin, Injection Solution, 300 Mcg (1500 Iu)/2 Ml, 2 Ml; Methylpredn ...
- UAT Ref No: 123668413
- Deadline: 02 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 832906
- Notice Type: Tender
- Document Ref. No.: UA-2025-07-30-005721-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Ciprofloxacin solution for infusions, 2 mg/ml of 100 ml; Levonorgestrel, intrauterine system, 52 mg; Human anti-D immunoglobulin, injection solution, 300 mcg (1500 IU)/2 ml, 2 ml; Methylprednisolone, powder and solvent for injection solution, 500 mg; Lidocaine, injection solution, 100 mg/ml, 2 ml; Neostigmine, injection solution, 0.5 mg/ml, 1 ml; Lidocaine, injection solution, 20 mg/ml, 2 ml; Ibuprofen solution for infusions of 4 mg/ml of 100 ml; Cyanocobalamin (vitamin B12), solution for injection, 0.5 mg/ml, 1 ml; Omeprazole capsules 20 mg; Glucose solution for infusion 5 % by 200 ml; Glucose solution for infusions 5 % at 400 ml; Glucose solution for infusions 5 % 500 ml; Glucose solution for infusions 5 % 1000 ml; Glucose solution for infusions 5 % of 3000 ml; Tranexamic acid tablets covered with a film sheath of 500 mg; Glucose solution for infusions 10 % at 400 ml; Glucose solution for injection 40 % of 10 ml; Magnesium sulfate, injection solution, 250 mg/ml, 5 ml; Povidone-iodine, external solution, 10 %, 100 ml; Prednisolone, solution for injection, 30 mg/ml, 1 ml; Omeprazole 40 mg vial; Diclofenac solution for injection 25 mg/ml; Drotaverin solution for injection of 20 mg/ml, 2 ml in ampoule; Piperacillin/tazobactam, powder (lyophilisate) for solution, 4 g/0.5 g
Type of purchase: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Ciprofloxacin solution for infusions, 2 mg/ml of 100 ml, levonorgestrel, intrauterine system, 52 mg, anti-D immunoglobulin human solution, 300 mcg (1500 IU)/2 ml, 2 ml, methylprednisolone, powder and solvent for injection solution, 500 mg, lidocaine, injection solution, 100 mg/ml, 2 ml, neostigmine, injection solution, 0,5 mg/ml. 2 ml, ibuprofen solution for infusions 4 mg/ml 100 ml, cyanocobalamin (vitamin B12), solution for injection, 0.5 mg/ml, 1 ml, omeprazole capsules 20 mg, glucose solution for infusions 5 % at 200 ml, glucose solution for infusions 5 % 5 %, glucose for infusions for infusions. 1000 ml, glucos... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCiprofloxacin Solution for Infusions, 2 Mg/Ml of 100 Ml; Levonorgestrel, Intrauterine System, 52 Mg; Human Anti-D Immunoglobulin, Injection Solution, 300 Mcg (1500 Iu)/2 Ml, 2 Ml; Methylpredn ... - Ukraine Tender
The THE MUNICIPAL ENTERPRISE "4-A CITY CLINICAL HOSPITAL OF POLTAVA CITY COUNCIL NAMED AFTER LEONID KUROEDOV, a Government sector organization in Ukraine, has announced a new tender for Ciprofloxacin Solution for Infusions, 2 Mg/Ml of 100 Ml; Levonorgestrel, Intrauterine System, 52 Mg; Human Anti-D Immunoglobulin, Injection Solution, 300 Mcg (1500 Iu)/2 Ml, 2 Ml; Methylpredn .... This tender is published on UkraineTenders under UAT Ref No: 123668413 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-02.
The estimated tender value is UAH 832906, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
